Editors note: Part 3 of 3

ACCORDING TO KPMG’S STUDY, “Medical devices 2030: Making a power play to avoid the commodity trap,” analysts predict the introduction of numerous innovations to orthopedic care, such as Johnson & Johnson partnering with a leading technology company, adopting 3D printing capabilities to customize orthopedic products for better healthcare outcomes and reduced costs. The September issue looked at the future of ophthalmic care, October covered cardiovascular device manufacturing.


  • Global annual sales forecast:
    • +5% per year
  • $800 billion by 2030
  • Increasing demand for innovative new devices


  • 3D-printed surgical planning models, instruments – next 5 years
  • Autonomous surgical robots – 5-to-10 years
  • Augmented reality assisted surgeries – 5-to-10 years

Innovative surgical interventions such as autonomous surgical robots and intelligent balloon catheters will enhance outcomes of complex surgeries and enable new forms of minimally invasive surgeries. Stryker has placed large bets in this space, given their strong orthopedics focus. In March 2017, the company launched the robotic-arm assisted total knee arthroplasty application for use with its Mako robot system. The technology is the first of its kind for total knee replacement, gained FDA approval in 2015, and is now commercially available for use in the U.S. ~ KPMG